State Street
NUVB icon

State Street’s Nuvation Bio NUVB Stock Holding History

State Street’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.9M Buy
7,370,794
+585,867
+9% +$2.86M ﹤0.01% 1964
2026
Q1 		$29.1M Buy
6,784,927
+926,145
+16% +$5.16M ﹤0.01% 2036
2025
Q4 		$52.5M Sell
5,858,782
-230,403
-4% -$1.43M ﹤0.01% 1713
2025
Q3 		$22.5M Buy
6,089,185
+530,201
+10% +$1.44M ﹤0.01% 2173
2025
Q2 		$10.8M Buy
5,558,984
+702,968
+14% +$1.46M ﹤0.01% 2548
2025
Q1 		$8.55M Buy
4,856,016
+256,023
+6% +$583K ﹤0.01% 2630
2024
Q4 		$12.2M Buy
4,599,993
+433,552
+10% +$1.12M ﹤0.01% 2511
2024
Q3 		$9.54M Buy
4,166,441
+191,031
+5% +$583K ﹤0.01% 2635
2024
Q2 		$11.6M Buy
3,975,410
+931,900
+31% +$2.84M ﹤0.01% 2475
2024
Q1 		$11.1M Sell
3,043,510
-18,704
-0.6% -$35.9K ﹤0.01% 2520
2023
Q4 		$4.62M Buy
3,062,214
+33,069
+1% +$42.6K ﹤0.01% 2984
2023
Q3 		$4.06M Buy
3,029,145
+7,699
+0.3% +$12.8K ﹤0.01% 3025
2023
Q2 		$5.44M Buy
3,021,446
+228,039
+8% +$388K ﹤0.01% 2957
2023
Q1 		$4.64M Buy
2,793,407
+135,695
+5% +$275K ﹤0.01% 3025
2022
Q4 		$5.1M Sell
2,657,712
-412,686
-13% -$835K ﹤0.01% 3032
2022
Q3 		$6.88M Buy
3,070,398
+122,284
+4% +$349K ﹤0.01% 2902
2022
Q2 		$9.55M Sell
2,948,114
-48,733
-2% -$213K ﹤0.01% 2752
2022
Q1 		$15.8M Buy
2,996,847
+262,811
+10% +$1.48M ﹤0.01% 2562
2021
Q4 		$23.2M Buy
2,734,036
+1,330,900
+95% +$12.2M ﹤0.01% 2372
2021
Q3 		$13.9M Buy
1,403,136
+482,631
+52% +$4.37M ﹤0.01% 2691
2021
Q2 		$8.57M Buy
920,505
+878,005
+2,066% +$10M ﹤0.01% 2992
2021
Q1 		$444K Buy
+42,500
New +$475K ﹤0.01% 3747

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street's NUVB Position: Q2 2026 in Review

State Street increased its Nuvation Bio (NUVB) stake by 8.6% in Q2 2026, buying an estimated $2.86M and bringing the position to 7,370,794 shares worth $41.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1964.

State Street first reported a position in NUVB in Q1 2021 and has held it in 22 quarters since. The position peaked at $52.5M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • State Street held 7,370,794 shares of Nuvation Bio worth $41.9M as of Q2 2026.
  • State Street bought 585,867 Nuvation Bio shares in Q2 2026, an estimated $2.86M.
  • Nuvation Bio made up ﹤0.01% of State Street's portfolio in Q2 2026, its #1964 holding.
  • State Street first reported a position in Nuvation Bio in Q1 2021 and has held it in 22 quarters since.
  • State Street's Nuvation Bio position peaked at $52.5M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.